Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 69

Results For "strategy"

740 News Found

Endimension receives Rs 2.3 crore in seed funding
Startup | September 23, 2021

Endimension receives Rs 2.3 crore in seed funding

The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity


Promising prospects for Indian pharma: CLSA
News | September 17, 2021

Promising prospects for Indian pharma: CLSA

CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report


Argenta acquires Klifovet to expand global footprint in animal health
Biotech | September 17, 2021

Argenta acquires Klifovet to expand global footprint in animal health

Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups


Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
Public Health | September 14, 2021

Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis

Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor


Giuliano Perfetti is the new CEO of Jubilant Biosys
Movement | September 08, 2021

Giuliano Perfetti is the new CEO of Jubilant Biosys

In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer


Sanofi buys Kadmon to grow its transplant business
Biotech | September 08, 2021

Sanofi buys Kadmon to grow its transplant business

It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)


Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
News | September 01, 2021

Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1

The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio


Johnson & Johnson booster dose indicate impressive results
Drug Approval | August 26, 2021

Johnson & Johnson booster dose indicate impressive results

New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.


Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory
News | August 26, 2021

Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory

In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative


Regimen launches world’s first personalised digital therapy for ED
Startup | August 25, 2021

Regimen launches world’s first personalised digital therapy for ED

The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe